Liver fibrosis assessment with semiquantitative indexes and image analysis quantification in sustained-responder and non-responder interferon-treated patients with chronic hepatitis C

被引:91
|
作者
Caballero, T
Pérez-Milena, A
Masseroli, M
O'Valle, F
Salmerón, FJ
Del Moral, RMG
Sánchez-Salgado, G
机构
[1] Univ Granada, Sch Med, Dept Pathol, Granada 18012, Spain
[2] Univ Granada, Univ Hosp, Granada 18012, Spain
[3] Univ Granada, Sch Med, Dept Internal Med, Granada 18012, Spain
关键词
hepatitis C; liver fibrosis; image analysis; automatic quantification; Knodell activity index; Scheuer activity grade; Knodell fibrosis scoring; Scheuer fibrosis staging; interferon;
D O I
10.1016/S0168-8278(01)00006-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The effect of interferon on the reduction of liver fibrosis is controversial. We aimed to compare semiquantitative methods with a quantitative digital image analysis system to assess liver fibrosis in biopsies from patients with chronic hepatitis and different responses to interferon, Methods: We studied 98 liver biopsies with chronic hepatitis C before and after recombinant interferon alfa-2 treatment, using conventional histological assessment, grading of histological activity, scoring/staging of fibrosis (Knodell and Scheuer), and quantification of fibrosis with image analysis (FibroQuant). Results: Sustained-responders to interferon showed a significant reduction in histological lesions and in their Knodell and Scheuer activity indexes. The semiquantitative systems showed no reduction in fibrosis, The FibroQuant application showed a significant reduction in porto-periportal and septal areas among sustained-responders (P < 0.001) and non-responders (P < 0.05), and in porto-periportal and septal fibrosis areas only in sustained-responders (P < 0.001), whereas the percentage of fibrosis increased in non-responders (P < 0.001). Conclusions: The Scheuer system is useful for the daily evaluation of fibrosis, but the FibroQuant application provides more objective data on the anti-fibrogenic effects of interferon, which include a reduction in the portoperiportal area in sustained-responders and non-responders, accompanied by a reduction in the area of fibrosis only when the viral replication has ceased. (C) 2001 European Association for the Study of the Liver. Published by Elsevier Science B,V, All rights reserved.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 50 条
  • [1] Treatment of interferon non-responder patients with chronic hepatitis C in Asia
    Nishioka, M.
    CHRONIC HEPATITIS: METABOLIC, CHOLESTATIC, VIRAL AND AUTOIMMUNE, 2007, 157 : 110 - 118
  • [2] Early prediction of sustained viral responder and non-responder during interferon and ribavirin combination therapy in chronic hepatitis C
    Nakamura, H
    HEPATOLOGY RESEARCH, 2005, 33 (04) : 269 - 271
  • [3] Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
    Fontana, Robert J.
    Dienstag, Jules L.
    Bonkovsky, Herbert L.
    Sterling, Richard K.
    Naishadham, Deepa
    Goodman, Zachary D.
    Lok, Anna S. F.
    Wright, Elizabeth C.
    Su, Grace L.
    GUT, 2010, 59 (10) : 1401 - 1409
  • [4] Consensus interferon for earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    Emmett, C
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [5] New treatment strategies in non-responder patients with chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Bekkering, FC
    van Rossum, TGJ
    JOURNAL OF HEPATOLOGY, 1999, 31 : 184 - 188
  • [6] Neutralizing antibodies to interferon alpha in a chronic hepatitis C patient non-responder to pegylated interferon
    Santantonio, Teresa
    Milella, Michele
    Antonelli, Guido
    Scagnolari, Carolina
    JOURNAL OF HEPATOLOGY, 2006, 45 (05) : 759 - 761
  • [7] Retreatment of non-responder or relapser chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Milella, M
    Santantonio, T
    Pietromatera, G
    Maselli, R
    Casalino, C
    Mariano, N
    Genchi, C
    Pastore, G
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (03): : 211 - 215
  • [8] Soluble interleukin 2 receptors plasma levels among responder and non-responder patients with chronic hepatitis C
    Montano-Loza, A
    Ramirez-Iglesias, MT
    Gutierrez-Reyes, GG
    Nuñez, R
    Cruz, S
    Gallegos, F
    Robles-Diaz, G
    Kershenobich, D
    HEPATOLOGY, 2005, 42 (04) : 675A - 675A
  • [9] EFFECTS OF CASCADE FILTRATION IN COMBINATION WITH INTERFERON AND RIBAVIRIN IN THE TREATMENT OF NON-RESPONDER CHRONIC HEPATITIS C PATIENTS
    Ramunni, A.
    Brescia, P.
    Burzo, M.
    Verno, L.
    Rendina, M.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2010, 33 (07): : 436 - 436
  • [10] Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1)
    Oguz, Dilek
    Cicek, Bahattin
    Filik, Levent
    Odemis, Bulent
    Kilic, Mesut
    Altintas, Engin
    Zengin, Neslihan
    Altiparmak, Emin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (04) : 580 - 583